MedTrace Logo

MetaNeb® Chest X-ray Study

NCT02871258 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2024-09-24

Study results available
· View outcomes & findings →

Summary

To study objective is to evaluate the impact of use of The MetaNeb® System in clearance of atelectasis, as demonstrated by improvement in chest x-rays. This is a a non-randomized open label study, with all subjects receiving treatment with The MetaNeb® System. Subjects who qualify for enrollment in the study will receive therapy with The MetaNeb® System following the labeled instructions for the device. Details of the treatment including duration and frequency will be defined in treatment procedures.

Conditions

  • Atelectasis

Interventions

DEVICE

The MetaNeb® System

Sponsors & Collaborators

  • Hill-Rom

    lead INDUSTRY

Principal Investigators

  • Thomas Diamant, M.D., F.C.C.P · Hoag Memorial Hospital, Newport Beach, CA

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-08-17
Completion
2017-08-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02871258 on ClinicalTrials.gov